These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4548549)

  • 1. Preliminary observations on the in vitro lymphocyte transformation from mice infected with Schistosoma mansoni troughout treatment with an antimonial.
    Pérez H; Pérez M; Payares G
    Rev Bras Biol; 1973; 33(4):547-52. PubMed ID: 4548549
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of the antibilharzial compound (Bilharcid) on Schistosoma mansoni in vitro and in vivo.
    Mahran SG; Shehata H; Abdulla WA; el-Raziky EH
    Egypt J Bilharz; 1976; 3(2):239-45. PubMed ID: 1037637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune-dependence of schistosomicidal chemotherapy: relative lack of efficacy of an antimonial in Schistosoma mansoni-infected mice deprived of their T-cells and the demonstration of drug-antiserum synergy.
    Doenhoff MJ; Bain J
    Clin Exp Immunol; 1978 Aug; 33(2):232-8. PubMed ID: 309809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive therapy with MsbE and Astiban in hamsters infected with Schistosoma mansoni.
    Baldewsing R
    Trop Geogr Med; 1973 Jun; 25(2):174-8. PubMed ID: 4736841
    [No Abstract]   [Full Text] [Related]  

  • 5. Clearance of in vitro prepared heterologous antigen-antibody complexes in mice infected with Schistosoma mansoni.
    Kestens L; Van Marck EA; Gigase PL
    Contrib Microbiol Immunol; 1983; 7():63-72. PubMed ID: 6600672
    [No Abstract]   [Full Text] [Related]  

  • 6. A new approach for screening prophylactic agents in schistosomiasis.
    Pereira LH; Pellegrino J; Valadares TE; Mello RT; Coelho PM
    Rev Inst Med Trop Sao Paulo; 1974; 16(3):123-6. PubMed ID: 4425363
    [No Abstract]   [Full Text] [Related]  

  • 7. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
    Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
    J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice.
    Van Nassauw L; Toovey S; Van Op den Bosch J; Timmermans JP; Vercruysse J
    Travel Med Infect Dis; 2008 Sep; 6(5):253-8. PubMed ID: 18760248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosomal egg antigen-induced lymphocyte blastogenesis in experimental murine Schistosoma mansoni infection.
    Colley DG
    J Immunol; 1971 Nov; 107(5):1477-80. PubMed ID: 5000731
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro effects of artesunate on the survival of worm pairs and egg production of Schistosoma mansoni.
    Mitsui Y; Miura M; Aoki Y
    J Helminthol; 2009 Mar; 83(1):7-11. PubMed ID: 18845029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schistosoma mansoni and PGE1. Experimental study in vitro and in vivo].
    Cicchini T; Belli M; Tubili C; Bacca M; Cicchini P
    Ann Sclavo; 1980; 22(5):755-62. PubMed ID: 7271336
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of the host response in human schistosomiasis. IV. Parasite antigen induces release of histamine that inhibits lymphocyte responsiveness in vitro.
    Hofstetter M; Fasano MB; Ottesen EA
    J Immunol; 1983 Mar; 130(3):1376-80. PubMed ID: 6185579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of heme aggregation by chloroquine reduces Schistosoma mansoni infection.
    Oliveira MF; d'Avila JC; Tempone AJ; Soares JB; Rumjanek FD; Ferreira-Pereira A; Ferreira ST; Oliveira PL
    J Infect Dis; 2004 Aug; 190(4):843-52. PubMed ID: 15272414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of dietary protein level upon the response of mice infected with Schistosoma mansoni to treatment with niridazole (ambilhar).
    Fadl AM
    J Helminthol; 1971; 45(2):117-22. PubMed ID: 5123692
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of the substituent radicals in antimonyl naphthalein derivatives on the potentialities of anti-schistosomal activity in mice.
    Ghaleb HA; Shoeb HA; el-Gawhary N; el-Borolossy AW; el-Halawany SA; MADKOUR MK
    J Egypt Med Assoc; 1979; 62(1-2):31-43. PubMed ID: 262474
    [No Abstract]   [Full Text] [Related]  

  • 17. Schistosoma mansoni: early antimonial treatment of infected mice.
    Ercoli N; Payares G
    Exp Parasitol; 1974 Apr; 35(2):171-8. PubMed ID: 4821447
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening of three synthetic organic trivalent antimonials for potential antischistosomal activity in mice.
    Ghaleb HA; Shoeb H; el-Kawhary N; el-Borolossy AW; el-Halawany SA; Madkour MK
    J Egypt Med Assoc; 1979; 62(1-2):1-29. PubMed ID: 262466
    [No Abstract]   [Full Text] [Related]  

  • 19. A monoclonal antibody from infected mice to a Schistosoma mansoni egg proteinase.
    Dresden MH; Sung CK; Deelder AM
    J Immunol; 1983 Jan; 130(1):1-3. PubMed ID: 6336621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosoma mansoni: autoantibodies and polyclonal B cell activation in infected mice.
    Fischer E; Camus D; Santoro F; Capron A
    Clin Exp Immunol; 1981 Oct; 46(1):89-97. PubMed ID: 6978217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.